{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T20:16:06Z","timestamp":1722975366544},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125851","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T14:16:37Z","timestamp":1430489797000},"page":"e0125851","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incorporation of Porcine Adenovirus 4 Fiber Protein Enhances Infectivity of Adenovirus Vector on Dendritic Cells: Implications for Immune-Mediated Cancer Therapy"],"prefix":"10.1371","volume":"10","author":[{"given":"Ivy","family":"Wilkinson-Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sojung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferhat","family":"Ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindzy","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon P.","family":"Goedegebuure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00262-011-1023-5","article-title":"Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study","volume":"60","author":"C Bauer","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-0039.2010.01615.x","article-title":"Dendritic cells in networks of immunological tolerance","volume":"77","author":"S Gregori","year":"2011","journal-title":"Tissue Antigens"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2796.2010.02317.x","article-title":"Dendritic cells and immunity against cancer","volume":"269","author":"K Palucka","year":"2011","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.smim.2011.01.004","article-title":"Targeting human dendritic cell subsets for improved vaccines","volume":"23","author":"H Ueno","year":"2011","journal-title":"Semin Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00262-011-1138-8","article-title":"Regulatory dendritic cells in the tumor immunoenvironment","volume":"61","author":"GV Shurin","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"J Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e22664","DOI":"10.4161\/onci.22664","article-title":"Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer","volume":"2","author":"LE Kandalaft","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ygyno.2005.09.040","article-title":"HPV16\/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities","volume":"100","author":"AD Santin","year":"2006","journal-title":"Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1752-8062.2008.00070.x","article-title":"Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma","volume":"1","author":"IC Leao","year":"2008","journal-title":"Clin Transl Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e46981","DOI":"10.1371\/journal.pone.0046981","article-title":"Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector","volume":"7","author":"BJ Williams","year":"2012","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/rmv.612","article-title":"Adenovirus receptors: implications for tropism, treatment and targeting","volume":"19","author":"N Arnberg","year":"2009","journal-title":"Rev Med Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.003087-0","article-title":"Adenoviruses: update on structure and function","volume":"90","author":"WC Russell","year":"2009","journal-title":"J Gen Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virusres.2009.02.010","article-title":"Adenovirus receptors and their implications in gene delivery","volume":"143","author":"A Sharma","year":"2009","journal-title":"Virus Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2010.08.010","article-title":"An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations","volume":"407","author":"M Murakami","year":"2010","journal-title":"Virology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1743-422X-7-276","article-title":"Characterization of human adenovirus 35 and derivation of complex vectors","volume":"7","author":"D McVey","year":"2010","journal-title":"Virol J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e55533","DOI":"10.1371\/journal.pone.0055533","article-title":"An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer","volume":"8","author":"JW Kim","year":"2013","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ni948","article-title":"Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A","volume":"4","author":"DM Zajonc","year":"2003","journal-title":"Nat Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"C van Kooten","year":"2000","journal-title":"Journal of Leukocyte Biology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"21181","DOI":"10.1074\/jbc.270.36.21181","article-title":"Both Extracellular Immunoglobin-like Domains of CD80 Contain Residues Critical for Binding T Cell Surface Receptors CTLA-4 and CD28","volume":"270","author":"RJ Peach","year":"1995","journal-title":"Journal of Biological Chemistry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.2910500308","article-title":"Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium","volume":"50","author":"K Chang","year":"1992","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.pai.00000141545.36485.d6","article-title":"Localization of mesothelin in epithelial ovarian cancer","volume":"13","author":"R Hassan","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/F1B64CL7H8VJKEAF","article-title":"Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis","volume":"124","author":"R Hassan","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"A Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/BJ20110282","article-title":"Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK\/ERK and JNK pathways","volume":"442","author":"MC Chang","year":"2012","journal-title":"Biochem J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e33214","DOI":"10.1371\/journal.pone.0033214","article-title":"Inhibition of mesothelin as a novel strategy for targeting cancer cells","volume":"7","author":"K Wang","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/1078-0432.CCR-11-2121","article-title":"A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction","volume":"18","author":"DT Le","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.vaccine.2006.06.087","article-title":"A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors","volume":"25","author":"CF Hung","year":"2007","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/IR:32:1-3:109","article-title":"Applications of major histocompatibility complex class I molecules expressed as single chains","volume":"32","author":"T Primeau","year":"2005","journal-title":"Immunol Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"27105","DOI":"10.1074\/jbc.M303716200","article-title":"Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide","volume":"278","author":"L Lybarger","year":"2003","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/1078-0432.CCR-04-2304","article-title":"Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients","volume":"11","author":"M Ho","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.20031435","article-title":"Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients","volume":"200","author":"AM Thomas","year":"2004","journal-title":"J Exp Med"},{"key":"ref32","unstructured":"BIMAS. National Institue of Health."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.vaccine.2009.10.096","article-title":"Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens","volume":"28","author":"L Li","year":"2010","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/JVI.75.9.4176-4183.2001","article-title":"Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin","volume":"75","author":"V Krasnykh","year":"2001","journal-title":"J Virol"},{"key":"ref35","first-page":"115","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"JV Maizel Jr.","year":"1968","journal-title":"Virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/CJI.0b013e3181b56deb","article-title":"Selective transduction of mature DC in human skin and lymph nodes by CD80\/CD86-targeted fiber-modified adenovirus-5\/3","volume":"32","author":"R van de Ven","year":"2009","journal-title":"J Immunother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.virol.2004.02.016","article-title":"Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors","volume":"322","author":"JJ Short","year":"2004","journal-title":"Virology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1016\/j.vaccine.2009.09.055","article-title":"A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo","volume":"27","author":"EE Thacker","year":"2009","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.185.12.2043","article-title":"HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice","volume":"185","author":"S Pascolo","year":"1997","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0167-5699(94)90006-X","article-title":"The immunobiology of muscle","volume":"15","author":"R Hohlfeld","year":"1994","journal-title":"Immunol Today"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"158128","DOI":"10.1155\/2014\/158128","article-title":"The early activation of CD8+ T cells is dependent on type I IFN signaling following intramuscular vaccination of adenovirus vector","volume":"2014","author":"M Hemmi","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20092618","article-title":"Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells","volume":"207","author":"LF Poulin","year":"2010","journal-title":"J Exp Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.20100223","article-title":"The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells","volume":"207","author":"K Crozat","year":"2010","journal-title":"J Exp Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ymthe.2004.02.006","article-title":"Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule","volume":"9","author":"AV Pereboev","year":"2004","journal-title":"Mol Ther"},{"key":"ref45","first-page":"5456","article-title":"Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model","volume":"60","author":"BW Tillman","year":"2000","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1158\/0008-5472.CAN-11-0804","article-title":"Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine","volume":"71","author":"BN Hangalapura","year":"2011","journal-title":"Cancer Res"},{"key":"ref47","first-page":"275","article-title":"Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells","volume":"8","author":"A Kanerva","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3171\/JNS-07\/09\/0617","article-title":"Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells","volume":"107","author":"IV Ulasov","year":"2007","journal-title":"J Neurosurg"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ygyno.2013.06.003","article-title":"A phase I clinical trial of Ad5\/3-Delta24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer","volume":"130","author":"KH Kim","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.gt.3302588","article-title":"A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy","volume":"12","author":"MA Stoff-Khalili","year":"2005","journal-title":"Gene Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T08:09:27Z","timestamp":1566634167000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125851"}},"subtitle":[],"editor":[{"given":"Natalia","family":"Lapteva","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125851","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,1]]}}}